Currently flying under Wall Street's radar, I've unearthed a new biotech profile trading on the NYSE American you need to get on your watch-

SmallCapFirm

On Lookout: This New NYSE Biotech Has Over 275% Potential Upside To Analysts' Consensus Target

Be Ready At 9:30AM EST Wednesday For Your Full Report

Sign Up To My SMS Update System Today (Info Below)

October 20th

SCF Readers,

Currently flying under Wall Street's radar, I've unearthed a new biotech profile trading on the NYSE American you need to get on your watch-list immediately.

Tomorrow at 9:30AM EST, you get the full report.

Remember Monday's Nasdaq profile DARE? Throughout the day, it battled with its: 50-Day SMA, 200-Day SMA, and 13-Day EMA.

If those levels are able to break down in the short-term, it could receive some serious buzz for a potential support-backed squeeze towards a vertical move.

Keep DARE on radar, but also get ready for this new biotech idea by checking out 3 potential catalysts now:

3 Potential Catalysts For This New NYSE American Profile

#1. A consensus price target from multiple analysts gives this NYSE idea over 275% in upside potential from current trading levels.

#2. Throughout 2020, this profile has shown the potential to deliver multi-dollar runs in the short-term. With big recent news, could this biotech's next major breakout be right around the corner?

#3. With fewer than 13Mn shares in its float, according to Yahoo Finance, volatility could create the potential for a vertical surge.

Right now, I suggest doing one thing to prepare:

image

Be on the lookout bright and early tomorrow.

Sincerely,

Axel Adams

Editor, SCF


(Always Remember The Stock Prices Could Be Significantly Lower Now From The Dates I Provided.)​

Disclosure: Make sure to always do your own research and due diligence on any day and swing trade profile I bring to your attention. I am not a license d finan.cial advise r. All potential percentage gains are based on from the low to the high of day. SmallCapFirm's full disclosure is to be read and fully understood before using SmallCapFirm's website, or joining SmallCapFirm's email or text list. By viewing SmallCapFirm's website and/or reading SmallCapFirm's email or text newsletter you are agreeing to SmallCapFirm's full disclosure which can be read at: smallcapfirm.com/disclosure Stock Wire News (stock wire news . com) is owned by Stock News Wire LLC, a limited liability company. An owner of Stock News Wire, LLC owns an interest in the limited liability company that owns and operates small cap firm . com (“SCF”), an interest in the limited liability company that owns and operates fierce investor . com (“FI”), an interest in the limited liability company that owns and operates stock street wire . com (SSW), and an interest in the limited liability company that owns and operates nasdaq wire news . com (NWN) . From time to time, Stock Wire News, SCF, FI, SSW, and/or NWN will publicly disseminate information about a company via website, email, SMS and other points of media. Pursuant to an agreement between SmallCapFirm (SCF) and Stock News Wire LLC, SCF has been hired for a one day period beginning on 10/19/20 to publicly disseminate information about (DARE) via Website, Email and SMS. We have been paid five thousand USD via bank wire transfer. We own zero shares of (DARE). An owner of Stock News Wire LLC owns an interest in SmallCapFirm (SCF). Pursuant to an agreement between Stock News Wire LLC and Complete Investment Management LLC, StockWireNews has been hired for a one day period beginning on 10/19/20 to publicly disseminate information about (DARE) via Website, Email and SMS. Stock News Wire LLC was paid thirty thousand USD via bank wire transfer. Stock Wire News owns zero shares of (DARE). A holder or two holders of DARE have paid Stock News Wire, LLC the sum of thirty thousand USD to publish favorable information about DARE. The holder or the two holders intend to sell their shares of DARE while we publish favorable information about DARE. Please see the full disclaimer here: stock wire news . com.